|
21. |
Staffa, J.A., Newschaffer, C.J.,et al, "Progestins and breast cancer: an epidemiologic review", Fertility and Sterility, Vol 57, No 3, Mar 1992, pp473-91. |
|
22. |
Harlap, S., "Oral contraceptives and breast cancer: cause and effect?", Journal of Reproductive Medicine, Vol 36, No 5, May 1991, pp374-95. |
|
23. |
Thomas, D.B., "Oral contraceptives and breast cancer: review of the epidemiologic literature", Contraception, Vol 43, No 6, Jun 1991, pp597-642. |
|
24. |
Szarewski, A. and Guillebaud, J., "Contraception: current state of the art", British Medical Journal, Vol 302, 25 May 1991, pp1224-6. |
|
25. |
McPherson, К., "Combined progestin and estrogen (oral) and other forms of hormonal contraception", Current Opinion in Obstetrics and Gynecology, Vol 3, 1991, pp486-90. |
|
26. |
Djerassi, С., "The bitter pill", Science, Vol 245, 28 Jul 1989, pp356-60. |
|
27. |
Vessey, M.P., "Oral contraception and cancer", chapter 4 in: Pilshie and Guillebaud, 1989, op cit, p63. |
|
28. |
Thomas, D.B., "The WHO Collaborative Study of Neoplasia and Steroid Contraceptives: the influence of combined oral contraceptives on risk of neoplasms in developing and developed countries", Contraception, Vol 43, No 6, June 1991, pp695-710. |
|
29. |
Guillebaud, 1991, Contraception, op cit, p43. |
|
30. |
Arron., "Japan's wait for low dose 'pill", Lancet, Vol 339, 4 Apr 1992, p865. |
|
31. |
Guillebaud, 1991, Contraception, op cit, p152. |
|
32. |
Vessey, 1989, op cit, pp63-4; Hsing, A.W., Hoover, R.N., et al, "Oral contraceptive use and primary liver cancer among young women", Cancer Causes and Control, Vol 3, 1992, pp43-8. |
|
33. |
AMA, Drug Evaluations, Philadelphia, W.B. Saunders Co., (6th edn) 1986, p724. |
|
34. |
Parish, P., Medicines: a guide for everybody, London, Penguin (6th edn, revised), 1989, p247. |
|
BMA and the Royal Pharmaceutical Society of Great Britain, British National Formulary, London, BMA and The Pharmaceutical Press, No 23, Mar 1992, pp23\83 and 286. |
|
|
35. |
Ibid, p240. |
|
36. |
Berer, 1989, op cit, p292. |
|
37. |
Drife, J., "Complications of combined oral contraception", chapter 3 in: Filshie and Guillebaud, 1989, op cit, p45. |
|
38. |
Petitti, D.B. andPorterfield, D., "Worldwide variations in the lifetime probability of reproductive cancer in women: implications of best-case, worst-case and likely-case assumptions about the effect of oral contraceptive use", Contraception, Vol 45, No 2, Feb 1992, pp93-104. |
|
39. |
Mishell Jr, D.R., "Contraception", New England Journal of Medicine, Vol 320, No 12, 23 Mar 1989, pp777-87. |
|
40. |
Parish, 1989, op cit, p247. — 264 —
|